Desq Long
Sign in

Company

SOPHiA GENETICS SA

SOPH · CIK 0001840706

SEC FORM 4
$28,727.20

SOPHiA GENETICS SA (SOPH)

Sale of 4,000 shares at $7.1818 per share.

Reporting Person Xu Zhenyu · Officer Title Chief Scientific Officer · Transaction Code S

Traded Oct 13, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001840706-26-000343 · filed 2026-10-14 · View filing →

SEC FORM 4
$61,670.90

SOPHiA GENETICS SA (SOPH)

Sale of 8,500 shares at $7.2554 per share.

Reporting Person Camblong Jurgi · Officer Title Executive Chairman · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001840706-26-000340 · filed 2026-10-14 · View filing →

SEC FORM 4
$36,303.00

SOPHiA GENETICS SA (SOPH)

Sale of 5,000 shares at $7.2606 per share.

Reporting Person Menu Philippe · Officer Title Chief Medical Officer · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001840706-26-000344 · filed 2026-10-14 · View filing →

SEC FORM 4
$79,971.13

SOPHiA GENETICS SA (SOPH)

Sale of 9,838 shares at $8.1288 per share.

Reporting Person Muken Ross · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001840706-26-000328 · filed 2026-10-07 · View filing →

SEC FORM 4
$60,074.77

SOPHiA GENETICS SA (SOPH)

Sale of 7,394 shares at $8.1248 per share.

Reporting Person Xu Zhenyu · Officer Title Chief Scientific Officer · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001840706-26-000329 · filed 2026-10-07 · View filing →

SEC FORM 4
$326,526.05

SOPHiA GENETICS SA (SOPH)

Sale of 40,172 shares at $8.1282 per share.

Reporting Person Camblong Jurgi · Officer Title Executive Chairman · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001840706-26-000330 · filed 2026-10-07 · View filing →

SEC FORM 4
$60,099.91

SOPHiA GENETICS SA (SOPH)

Sale of 7,394 shares at $8.1282 per share.

Reporting Person Menu Philippe · Officer Title Chief Medical Officer · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001840706-26-000331 · filed 2026-10-07 · View filing →

SEC FORM 4
$12,897.43

SOPHiA GENETICS SA (SOPH)

Sale of 1,592 shares at $8.1014 per share.

Reporting Person CARDOZA GEORGE · Officer Title Chief Financial Officer · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001840706-26-000332 · filed 2026-10-07 · View filing →

SEC FORM 4
$1,491.10

SOPHiA GENETICS SA (SOPH)

Sale of 185 shares at $8.06 per share.

Reporting Person Puylaert Kevin · Officer Title Chief Sales Officer · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001840706-26-000333 · filed 2026-10-07 · View filing →

SEC FORM 4
$245.52

SOPHiA GENETICS SA (SOPH)

Sale of 31 shares at $7.92 per share.

Reporting Person Puylaert Kevin · Officer Title Chief Sales Officer · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001840706-26-000333 · filed 2026-10-07 · View filing →

SEC FORM 4
$42,928.80

SOPHiA GENETICS SA (SOPH)

Sale of 5,284 shares at $8.1243 per share.

Reporting Person Verma Abhimanyu · Officer Title Chief Technology Officer · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001840706-26-000334 · filed 2026-10-07 · View filing →

SEC FORM 4
$34,487.31

SOPHiA GENETICS SA (SOPH)

Sale of 4,240 shares at $8.1338 per share.

Reporting Person Valente Manuela · Officer Title Chief People Officer · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001840706-26-000335 · filed 2026-10-07 · View filing →

SEC FORM 4
$50,100.20

SOPHiA GENETICS SA (SOPH)

Sale of 6,168 shares at $8.1226 per share.

Reporting Person Van Well Daan · Officer Title Chief Legal Officer · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001840706-26-000336 · filed 2026-10-07 · View filing →

SEC FORM 4
$3,515.26

SOPHiA GENETICS SA (SOPH)

Sale of 422 shares at $8.33 per share.

Reporting Person Muken Ross · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001840706-26-000317 · filed 2026-09-22 · View filing →

SEC FORM 4
$6,447.42

SOPHiA GENETICS SA (SOPH)

Sale of 774 shares at $8.33 per share.

Reporting Person CARDOZA GEORGE · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 21, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0001840706-26-000318 · filed 2026-09-22 · View filing →

SEC FORM 4
$31,537.60

SOPHiA GENETICS SA (SOPH)

Sale of 4,000 shares at $7.8844 per share.

Reporting Person Xu Zhenyu · Officer Title Chief Scientific Officer · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001840706-26-000313 · filed 2026-09-16 · View filing →

SEC FORM 4
$39,416.50

SOPHiA GENETICS SA (SOPH)

Sale of 5,000 shares at $7.8833 per share.

Reporting Person Menu Philippe · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001840706-26-000314 · filed 2026-09-16 · View filing →

SEC FORM 4
$47,088.98

SOPHiA GENETICS SA (SOPH)

Sale of 6,168 shares at $7.6344 per share.

Reporting Person Van Well Daan · Officer Title Chief Legal Officer · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001840706-26-000310 · filed 2026-09-14 · View filing →

SEC FORM 4
$65,120.20

SOPHiA GENETICS SA (SOPH)

Sale of 8,500 shares at $7.6612 per share.

Reporting Person Camblong Jurgi · Officer Title Executive Chairman · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001840706-26-000309 · filed 2026-09-14 · View filing →

SEC FORM 4
$50,817.50

SOPHiA GENETICS SA (SOPH)

Sale of 6,250 shares at $8.1308 per share.

Reporting Person HIBBS KATHY L · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001840706-26-000306 · filed 2026-09-10 · View filing →

SEC FORM 4
$89,096.00

SOPHiA GENETICS SA (SOPH)

Sale of 10,000 shares at $8.9096 per share.

Reporting Person Xu Zhenyu · Officer Title Chief Scientific Officer · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001840706-26-000304 · filed 2026-08-31 · View filing →

SEC FORM 4
$54,233.13

SOPHiA GENETICS SA (SOPH)

Sale of 6,250 shares at $8.6773 per share.

Reporting Person HIBBS KATHY L · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001840706-26-000301 · filed 2026-08-26 · View filing →

SEC FORM 4
$43,396.50

SOPHiA GENETICS SA (SOPH)

Sale of 5,000 shares at $8.6793 per share.

Reporting Person Menu Philippe · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001840706-26-000302 · filed 2026-08-26 · View filing →

SEC FORM 4
$44,000.00

SOPHiA GENETICS SA (SOPH)

Sale of 5,000 shares at $8.80 per share.

Reporting Person Verma Abhimanyu · Officer Title Chief Technology Officer · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001840706-26-000298 · filed 2026-08-26 · View filing →

SEC FORM 4
$41,000.00

SOPHiA GENETICS SA (SOPH)

Sale of 5,000 shares at $8.20 per share.

Reporting Person Verma Abhimanyu · Officer Title Chief Technology Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 26, 2026FILED +7 DAYS

Source: SEC Form 4 · 0001840706-26-000298 · filed 2026-08-26 · View filing →

SEC FORM 4
$45,446.67

SOPHiA GENETICS SA (SOPH)

Sale of 5,408 shares at $8.4036 per share.

Reporting Person Xu Zhenyu · Officer Title Chief Scientific Officer · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001840706-26-000292 · filed 2026-08-21 · View filing →

SEC FORM 4
$38,608.62

SOPHiA GENETICS SA (SOPH)

Sale of 4,592 shares at $8.4078 per share.

Reporting Person Xu Zhenyu · Officer Title Chief Scientific Officer · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001840706-26-000292 · filed 2026-08-21 · View filing →

SEC FORM 4
$79,427.00

SOPHiA GENETICS SA (SOPH)

Sale of 10,000 shares at $7.9427 per share.

Reporting Person Xu Zhenyu · Officer Title Chief Scientific Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001840706-26-000292 · filed 2026-08-21 · View filing →

SEC FORM 4
$32,000.00

SOPHiA GENETICS SA (SOPH)

Acquisition (code M) of 10,000 shares at $3.20 per share.

Reporting Person Valente Manuela · Officer Title Chief People Officer · Transaction Code M

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001840706-26-000293 · filed 2026-08-21 · View filing →

SEC FORM 4
$79,439.00

SOPHiA GENETICS SA (SOPH)

Sale of 10,000 shares at $7.9439 per share.

Reporting Person Valente Manuela · Officer Title Chief People Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001840706-26-000293 · filed 2026-08-21 · View filing →

SEC FORM 4
$30,076.40

SOPHiA GENETICS SA (SOPH)

Sale of 4,000 shares at $7.5191 per share.

Reporting Person Xu Zhenyu · Officer Title Chief Scientific Officer · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001840706-26-000282 · filed 2026-08-14 · View filing →

SEC FORM 4
$37,579.50

SOPHiA GENETICS SA (SOPH)

Sale of 5,000 shares at $7.5159 per share.

Reporting Person Menu Philippe · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001840706-26-000283 · filed 2026-08-14 · View filing →